"During an unprecedented NICE submission process, the Tolley team were there as part of our team supporting and driving us to a successful outcome. The team provided not only strategic support in the development of the dossier to clearly position us for success but were integral partners throughout the process, helping us finalise the recommendation with NICE. The team worked above and beyond to meet some extensive requests to very tight deadlines and always with good spirit, and when needed, humour."

"Tolley have led on the NICE and SMC submissions for one of our treatments for a rare disease. The submissions were complex and nuanced, depending on considerable expertise in building the economic case and ensuring the severity of the condition was properly emphasised in the narrative. The team at Tolley proved to be excellent partners for these processes, becoming true experts on the therapy area and treatment. We found the staff at Tolley to be experts in the their field, responsive to queries and able to offer strategic advice on the most appropriate approach at all stages of the submissions. Outstanding project management, excellent health economic modelling and impressive medical writing led to both submissions being approved. I fully expect to continue working with Tolley on future market access projects."

"My experience of representing the EAG when Tolley were advising the company has always been positive. All requested analyses have been completed, or valid reasons presented as to why these could not be done, and the process has been conducted in a supportive, rather than adversarial manner which has resulted in a smoother STA process"